Header cover image

Indian (NIFTY) Biotech Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies8
  • 7D-0.9%
  • 3M5.3%
  • 1Y-12.1%
  • YTD-18.8%

Over the last 7 days, the Biotech industry has remained flat, although notably Panacea Biotec gained 11%. Unfortunately though, the industry is down 12% over the past 12 months.

Industry Valuation and Performance

Has the Indian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021₹466.4b₹76.2b₹6.9b56x
Tue, 26 Oct 2021₹405.5b₹76.1b₹6.8b50.7x
Thu, 23 Sep 2021₹464.6b₹75.2b₹7.1b63.8x
Sat, 21 Aug 2021₹450.5b₹75.2b₹7.1b62x
Sat, 05 Jun 2021₹489.3b₹74.3b₹7.6b64.6x
Tue, 09 Mar 2021₹483.4b₹72.0b₹6.1b76.2x
Mon, 30 Nov 2020₹528.0b₹70.7b₹6.5b50.2x
Thu, 03 Sep 2020₹473.2b₹74.2b₹5.1b45.5x
Sun, 07 Jun 2020₹440.6b₹71.3b₹6.1b23.2x
Sat, 29 Feb 2020₹360.6b₹72.0b₹9.3b31.6x
Tue, 03 Dec 2019₹356.4b₹69.0b₹9.5b32.7x
Fri, 06 Sep 2019₹302.7b₹66.4b₹10.7b28.1x
Mon, 10 Jun 2019₹348.4b₹62.6b₹9.7b31.5x
Sun, 03 Mar 2019₹392.7b₹59.4b₹7.6b43.7x
Wed, 05 Dec 2018₹391.7b₹54.5b₹6.3b46.9x
PE Ratio

46.9x

Total Market Cap: ₹391.7bTotal Earnings: ₹6.3bTotal Revenue: ₹54.5b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 56.0x which is higher than its 3-year average PE of 45.0x. It appears they are confident that earnings will grow faster in the future than they have historically.

Past Earnings Growth: The earnings for companies in the Biotechs industry have grown 3.0% per year over the last three years, and revenues for these companies have grown 12% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Biotech industry?

Biotech-0.95%

Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 45.0x. This is likely because analysts are expecting annual earnings growth of 43%, which is higher than its past year's earnings growth of 31% per year.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 43% over the next 5 years. This is better than it's past earnings growth rate of 31% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
531349 Panacea Biotec11.4%+₹1.3b0.6%PS1.8x
590057 Equippp Social Impact Technologies4.4%+₹427.8m1,439.8%PE84x
532039 Zenotech Laboratories6.1%+₹149.5m39.3%PE46x
526139 Transgene Biotek8.4%+₹24.2m-15.0%PS182.7x
532041 Hindustan Bio Sciences5.7%+₹2.3m55.1%PS10.5x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News